TechCrunch -
4 years ago
Hello and welcome back to our regular morning look at private companies, public markets and the gray space in between.
After spending perhaps more time than we should have recently trying to figure out what’s going on with the public markets, l...
TechCrunch -
4 years ago
There has been a steady drumbeat of news on the U.S.-China trade front since the start of the Trump administration. President Trump has made decoupling from China’s economy on on-again, off-again proposition. There was the trade conflict with weekly...
Mashable -
4 years ago
Read more...
{"player":{"description":"Now is the time to pick up that book you forgot about and give Netflix a break.","image":"https://mondrian.mashable.com/uploads%252Fvideo_uploaders%252Fdistribution_thumb%252Fimage%252F94600%252Feaa3b126-4c6...
The Guardian -
4 years ago
Outcry after man, 23, fell from wall after stun gun was fired in Haringey, north LondonA police officer has been placed under criminal investigation after a man was shot with a Taser weapon and left paralysed from the waist down, the Guardian has lea...
TechCrunch -
4 years ago
As earnings season winds down, we’re getting a solid picture on just how profoundly the COVID-19 pandemic has impacted corporations’ bottomline. Taiwan-based manufacturing giant Foxconn is among those companies that were utterly walloped over the pre...
TechCrunch -
4 years ago
Chris and Alex Naoumidis came to hypnotherapy through dresses.
As The New York Times reported last year, the two brothers initially started their careers as startup entrepreneurs with a peer-to-peer dress-sharing app for women. The Australian natives...
TechCrunch -
4 years ago
Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast, where we unpack the numbers behind the headlines.
Are you a regular Equity listener? Take our survey here! We talk about it on the show, and it’s embedded below in...
TechCrunch -
4 years ago
Therapeutics company Sorrento has made what it believes could be a breakthrough in potential treatment of SARS-CoV-2, the virus that leads to COVID-19. The company released details of its preclinical research on Friday, announcing that it has found a...